___

• Kal HB, Struikmans H. Radiotherapy during pregnan- cy: fact and fiction. Lancet Oncol 2005; 6: 328-333.
• Tewari KS. Cancer in pregnancy. In: DiSaia PJ, Creasman WT, eds. Clinical Gynecologic Oncology. 7th ed. Mosby: Elsevier; 2007: 468-531.
• Pavlidis NA. Coexistence of pregnancy and malignan- cy. Oncologist 2002; 7: 279- 287.
• Hall EJ, Giaccia AJ. Effects of radiation on the embryo and fetus. Radiobiology for the radiologist. 6th ed. Philadelphia: Lippincott; 2006; 168-180.
• Pereg D, Koren G, Lishner M. The treatment of Hodgkin’s and non-Hodgkin’s lymhoma in pregnancy. Haematologica 2007; 92: 1230-1237.
• Hoppe RT. Hodgkin’s disease. In: Perez CA, Brady LW, Halperin EC, Schmidt-Ullrich RK, eds. Principles and practice of Radiation Oncology. 4th ed. Philadelphia: Lippincott Williams and Wilkins; 2004: 2043-2063.
• Diehl V, Brillant C, Engert A, et al. HD10: Investigating reduction of combined modality treatment intensity in early stage Hodgkin’s lymphoma. Interim analysis of a randomized trial of the German Hodgkin Study Group (GHSG). J Clin Oncol (Meeting Abstracts) 2005; 23: 6506.
• Woo SY, Fuller LM, Cundiff JH, et al. Radiotherapy during pregnancy for clinical stages IA-IIA Hodgkin’s disease. Int J Radiat.Oncol Biol Phys. 1992; 23: 407- 412.
• Nuyttens JJ, Prado KL, Jenrette JM, Williams TE. Fetal dose during radiotherapy: clinical implementation and review of the literature. Cancer Radiother 2002; 6: 352-357.
• Zucali R, Marchesini R, De Palo G. Abdominal dosimetry for supradiaphragmatic irradiation of Hodgkin’s disease in pregnancy: experimental data and clinical consideration. Tumori 1981; 67: 203-208.
• Nisce LZ, Tome MA, He S, et al. Management of coex- isting Hodgkin’s disease and pregnancy. Am J Clin Oncol 1986; 9: 146-151.
• Mazonakis M, Varveris H, Fasoulaki M, Damilakis J. Radiotherapy of Hodgkin’s disease in early pregnancy: embryo dose measurements. Radiother Oncol 2003; 66: 333-339.
• Cygler J, Ding GX, Kendal W, Cross P. Fetal dose for a patient undergoing mantle field irradiation for Hodgkin’s disease. Med Dosim 1997; 22: 135-137.
• International Commission on Radiological Protection. Pregnancy and medical radiation. Ann ICRP 2000; 30: 1-43.
• International Commission on Radiological Protection. Biological effects after prenatal irradiation(embryo and fetus). Ann ICRP 2003; 33: 205-206.
• Hammer-Jacobsen E. Therapeutic abortion on account X-ray examination during pregnancy. Dan Med Bull 1959; 6: 113-122.
• Wagner LK, Lester RG, Saldana LR. Exposure of the pregnant patient to diagnostic radiations. 2nd ed. Madison, Wisconsin: Medical Physics Publishing; 1997.
• Stovall M, Blackwell CR, Cundiff J, Novack DH, et al. Fetal dose from radiotherapy with photon beams: Report of AAPM Radiation Therapy Committee Task Group no: 36. Med Phys 1995; 22: 63-82.
• Lishner M, Zemlickis D, Degendorfer P, et al. Maternal and fetal outcome following Hodgkin’s disease in pregnancy. Br J Cancer 1992; 65: 114-117.
• Sneed PK, Albright NW, War WM, et al. Fetal dose esti- mates for radiotherapy of brain tumors during pregnan- cy. Int J Radiat Oncol Biol Phys 1995; 32: 823-830.
• Antypas C, Sandilos P, Kouvaris J, et al. Fetal dose evaluation during breast cancer radiotherapy. Int J Radiat Oncol Biol Phys 1998; 40: 995-999.
• Greskovich JF, Macklis RM. Radiation therapy in preg- nancy: risk calculation and risk minimization. Seminars in Oncology 2000; 27: 633-645.
• Ioachim HL. Non-Hodgkin’s lymphoma in pregnancy: three cases and review of the literature. Arch Pathol Lab Med 1985; 109: 803-809.